Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of C4 Therapeutics's CFT-7455?
CFT-7455 is a small molecule commercialized by C4 Therapeutics, with a leading Phase II program in Anaplastic Large Cell Lymphoma...